FOXP3 and breast neoplasm: In contrast to its effects on cytotoxic immune cells, SI-2 treatment significantly reduced the number of Foxp3+ cells in E0771 breast tumors in C57BL/6J mice compared to vehicle-treated mice (Fig. 3E).